Avid Bioservices Inc (CDMO)

[peregr]

CJ, thanks for posting. Very interesting read that now answers a lot of questions.

The reason to transition as quickly as possible, and be known as a pure play CDMO- valuations of 15x-20x EBITDA (this is really a different perspective from the prior Board who said 5x-7x sales as they knew they were having problems achieving material EBITDA).

Revenue potential with current facilities of $100 million (and that is probably conservative). If I recall, Ronin mentioned EBITDA margins could be above 60%. This could get us above $20-the low hanging fruit.

This is before any bolt on acquisitions or expansion.

Then they noted the upside potential for investors with the licensing/sale of the R&D.

This should help one's individual analysis of the business model.

Potential for a lot of value here.